✦ LIBER ✦

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

✍ Scribed by P. Kwo; E. Lawitz; J. McCone; E. Schiff; J. Vierling; D. Pound; M. Davis; J. Galati; S. Gordon; N. Ravendhran; L. Rossaro; F. Anderson; I. Jacobson; R. Rubin; K. Koury; C. Brass; E. Chaudhri; J. Albrecht

Book ID: 117377015
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 52 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60006-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

995 INTERIM RESULTS FROM HCV SPRINT-1: R

995 INTERIM RESULTS FROM HCV SPRINT-1: RVR/EVR FROM PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRONTM (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHC

✍ P. Kwo; E. Lawitz; J. McCone; E. Schiff; J. Vierling; D. Pound; M. Davis; J. Gal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA

1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 OR -4 CHRONIC HEPATITIS C: SVR24 RESULTS FROM A RANDOMIZED PHASE 2B STUDY (AI447016)

✍ Bronowicki, J.-P.; Ratziu, V.; Gadano, A.; Thuluvath, P.J.; Bessone, F.; Martore 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

4 PROVE1: RESULTS FROM A PHASE 2 STUDY O

4 PROVE1: RESULTS FROM A PHASE 2 STUDY OF TELAPREVIR WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH HEPATITIS C

✍ J.G. Mchutchison; G.T. Everson; S.C. Gordon; I. Jacobson; R. Kauffman; L. McNair 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

223 Prove1: Results from a Phase 2 Study

223 Prove1: Results from a Phase 2 Study of Telaprevir with Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Subjects with Hepatitis C

✍ Everson, Gregory T.; Jacobson, Ira M.; Gordon, Stuart C.; McHutchison, John G.; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P1123 RESPONSE-GUIDED THERAPY WITH BOCEP

P1123 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS INFECTED WITH HCV GENOTYPE 1: INTERIM RESULTS FROM THE TriCo STUDY

✍ Ferenci, P.; Flisiak, R.; Caruntu, F.A.; Lengyel, G.; Hohmann, M.; Bakalos, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Efficacy of boceprevir, an NS3 protease

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

✍ Paul Y Kwo; Eric J Lawitz; Jonathan McCone; Eugene R Schiff; John M Vierling; Da 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 378 KB